CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Merck Sharp & Dohme Corp. vs. Ono Pharmaceutical Co., Ltd.

๐Ÿ“ก 5G SEP โ€ข ETSI Declared

Explore the PTAB proceeding IPR2016-01219 filed by Merck Sharp & Dohme Corp. on 2016-06-30. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2016-01219

Filing Date

2016-06-30

Accorded Filing Date

2016-06-30

Institution Decision Date

โ€”

Last Modified Date

2018-06-26

Proceeding Type

IPR

Termination Date

2017-01-25

Trial Status

Terminated-Settled

Parties & Counsel

Petitioner

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 14550585
Respondent Patent Number 9073994
Legal Expiration Date
2034-11-21 Active (8.0 yrs remaining)
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor Tasuku HONJO et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Terminated-Settled

Administrative Patent Judges (APJ Panel)

Panel assignment tracked upon institution decision entry

Board Decisions & Rulings (1)

Settlement before Institution 2017-01-25
Termination Settlement before institution
35 USC 317, 37 CFR 42.72, 37 CFR 42.74

Address and Attorney/Agent Information

127 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Sterne, Kessler, Goldstein & Fox P.L.L.C. - BMS
Customer Number 115018
Address 1101 K Street, NW, 10th Floor, Washington, DC, 20005, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
28912 Robert Sterne +1 202-772-8555
29021 Jorge Goldstein +1 202-371-2600
32705 Elliott Korsen +1 609-252-4741
32831 Tracy-Gene Durkin +1 202-371-2600
33876 Donald Featherstone +1 202-772-8629
33997 Michael Ray +1 202-772-8569
34395 Robert Millonig +1 202-371-2600
35239 Michael Lee +1 703-628-0233

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts 4 proceedings
๐Ÿ›๏ธ
USPTO PTAB Trials 1 proceeding
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Parallel Proceedings Across Jurisdictions (5 found):
PTAB: 1 U.S. Courts: 4
USPTO PTAB Trial 2016-06-29
IPR2016-01221

Merck Sharp & Dohme Corp. v. Ono Pharmaceutical Co., Ltd.

Asserted Patent
Status: Terminated-Settled
U.S. District Court 2017-07-26
1:17-cv-01029

Bristol-Myers Squibb Co. v. EMD Serono, Inc.

Asserted Patent
Status: DED
U.S. District Court 2015-07-07
1:15-cv-00572

Bristol-Myers Squibb Co. v. Merck & Co., Inc.

Asserted Patent
Status: DED
U.S. District Court 2015-06-30
1:15-cv-00560

Bristol-Myers Squibb Co. v. Merck & Co., Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-09-05
1:14-cv-01131

Bristol-Myers Squibb Co. v. Merck & Co Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Standard Essential Patent (SEP) & FRAND Intelligence

5G SEP โ€ข ETSI Declared High-Probability SEP Action

Essential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation

FRAND Encumbered
Essential Standard 4G / 5G LTE Generation: 5G
Standard Setting Org (SSO) ETSI / 3GPP Essential specification under ETSI / 3GPP governance
FRAND Commitment Committed Fair, Reasonable & Non-Discrim.
Known Patent Pools Avanci / Sisvel / Via Licensing Coverage Applicable Declarant: Sharp

Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)

Permanent Injunction Restricted

Asserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.

โœ“ Patentee bound by SSO IPR Policy (ETSI Annex 6 / IEEE Patent Policy).
โœ“ Right to demand global FRAND portfolio determination.
โœ“ Non-discrimination defense: check licensing terms offered to competing implementers.

Proceeding Documents

200
20

Notice of Refund Paper

2018-06-26 FILING PARTY: None
19

Petitioner's Request for Refund of Post-Institution Fees Paper

2018-06-18 FILING PARTY: None
18

Termination Settlement before institution Paper

2017-01-25 FILING PARTY: None
15

Joint Motion To Terminate Pursuant To 35 U.S.C. ยฟยฟ 317 Paper

2017-01-23 FILING PARTY: None
17

Patent Owners' Exhibit List Paper

2017-01-23 FILING PARTY: None

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc